Home > Income Statement > WANBURY

WANBURY
Revenue

    Back to Income Statement
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹600 Cr₹578 Cr₹500 Cr₹511 Cr₹393 Cr

What is the latest Revenue of WANBURY ?

The latest Revenue ratio of WANBURY is ₹600 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹600 Cr
Mar2024₹578 Cr
Mar2023₹500 Cr
Mar2022₹511 Cr
Mar2021₹393 Cr

How is Revenue of WANBURY Trending?

Years Revenue % Change
Mar2025 ₹600 Cr
3.77
Mar2024 ₹578 Cr
15.63
Mar2023 ₹500 Cr
-2.26
Mar2022 ₹511 Cr
30.23
Mar2021 ₹393 Cr -

Compare Revenue of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹796.4 Cr -4% -0.7% -5.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,077.0 Cr 1.6% 6% -2% Stock Analytics
DIVIS LABORATORIES ₹171,324.0 Cr -0.7% -1.9% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,235.0 Cr -0.8% 7.4% 21.2% Stock Analytics
CIPLA ₹123,294.0 Cr -0.4% -3.4% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,336.0 Cr 1.2% 0.3% -1.5% Stock Analytics


WANBURY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

-4%

-0.7%

-5.2%

SENSEX

0.9%

2.1%

8.3%


You may also like the below Video Courses